2014
DOI: 10.1051/medsci/20143005014
|View full text |Cite
|
Sign up to set email alerts
|

Nouveaux rôles physiopathologiques pour le récepteur PLA2R1 dans le cancer et la glomérulonéphrite extramembraneuse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0
2

Year Published

2014
2014
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 44 publications
0
1
0
2
Order By: Relevance
“…The second hypothesis proposes that the receptor could activate a cellular signaling pathway allowing an adequate answer of the cell to its changing environment [ 34 , 35 ]. However, besides the role of some intracellular motifs involved in its internalization properties, the exact downstream effectors of PLA2R1, which are the binding partners and the cellular signaling pathways that would be activated upon ligand binding, remain enigmatic [ 36 , 37 ]. For instance, PLA2R1 has been reported to be present in different immune cell types as mast cells, and neutrophils and may be involved in some sPLA 2 -induced effects [ 38 , 39 , 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…The second hypothesis proposes that the receptor could activate a cellular signaling pathway allowing an adequate answer of the cell to its changing environment [ 34 , 35 ]. However, besides the role of some intracellular motifs involved in its internalization properties, the exact downstream effectors of PLA2R1, which are the binding partners and the cellular signaling pathways that would be activated upon ligand binding, remain enigmatic [ 36 , 37 ]. For instance, PLA2R1 has been reported to be present in different immune cell types as mast cells, and neutrophils and may be involved in some sPLA 2 -induced effects [ 38 , 39 , 40 , 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…L'hydrolyse par la Lp-PLA2 produit essentiellement de la lysophosphatidylcholine, qui induit le recrutement monocytaire et la dégranulation des polynucléaires neutrophiles [8]. Les sPLA2 sont également produites par les cellules de l'immunité naturelle (monocytes/macrophages) et adaptative (lymphocytes T) [9], et par les cellules de la paroi vasculaire [38] ( §). Les sPLA2 des groupes IIA (GIIA), III (GIII) et V (GV) ont été identifiées dans les plaques d'athérosclérose chez la souris et chez l'homme [10].…”
Section: Lp-pla2 Et Risque Cardiovasculaireunclassified
“…Les principales manifestations du syndrome néphrotique incluent protéinurie (> 3 g/24h), hypoalbuminémie, oedèmes, hyperlipidémie (hypercholestérolémie et hypertriglycéridémie), et lipidurie. La néphropathie diabétique (ND), la néphropathie à lésions glomérulaires minimes (LGM), la glomérulosclérose segmentaire et focale (FSGS), et la glomérulopathie extra-membraneuse (GEM) [11], maladies classées parmi les néphropathies glomérulaires [1], sont les causes majeures du syndrome néphrotique. Malgré l'identification de protéines structurelles clés pouvant contribuer à des défauts de la filtration rénale, la plupart des mécanismes à l'origine du syndrome néphrotique ne sont toujours pas élucidés.…”
Section: Définition Du Syndrome Néphrotiqueunclassified